298
Participants
Start Date
January 11, 2012
Primary Completion Date
September 1, 2015
Study Completion Date
August 31, 2022
Abiraterone
Orally once daily
Apitolisib
Orally once daily
Ipatasertib
Orally once daily
Placebo
Orally once daily
Prednisone
Orally bid
Prednisolone
Orally bid
Corporacio Sanitaria Parc Tauli; Servicio de Oncologia, Sabadell
Weill Cornell Medical College, New York
New York Cancer and Blood Specialists - Setauket Medical Oncology, East Setauket
Irccs Ospedale San Raffaele;Oncologia Medica, Milan
Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, Milan
Johns Hopkins Univ; Bunting Blaustein Cancer Center, Baltimore
Azienda Ospedaliera Istituti Ospitalieri, Cremona
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid
Hospital Madrid Norte Sanchinarro, Madrid
Hospital Clinico Universitario Virgen de la Victoria, Málaga
Carolina Urologic Research Center, Myrtle Beach
Clinica Universitaria de Navarra, Pamplona
Florida Cancer Specialists; Sarasota, Sarasota
Sarah Cannon Cancer Center - Tennessee Oncology, Pllc, Nashville
IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola; Oncologia Medica, Meldola
Karmanos Cancer Institute, Detroit
ICO Paul Papin; Oncologie Medicale., Angers
Fakultni nemocnice Hradec Kralove; I. interni klinika,Oddeleni invazivni kardiologie, Hradec Králové
Ospedale S. Donato; Divisione Di Reumatologia, Arezzo
Urology Cancer Center & GU Research Network, Omaha
Centre Léon Bérard - Centre régional de lutte contre le cancer Rhône-Alpes, Lyon
Hia Du Val De Grace, Paris
Institut Curie; Oncologie Medicale, Paris
GH Paris Saint Joseph; Hopital De Jour Oncologie, Paris
HonorHealth Research Institute ? Bisgrove, Scottsdale
Pacific Hematology Oncology Associates, San Francisco
Hopital d'Instruction des Armees de Begin, Saint-Mandé
Institut Gustave Roussy; Departement Oncologie Medicale, Villejuif
Kaiser Permanente Medical Ctr, Honolulu
ONCOMED - Medical Centre, Timișoara
Prof. Dr. I. Chiricuta Institute of Oncology, Cluj-Napoca
Municipal Hosp Turdal; Oncology, Turda
Sf. Constantin Hospital; Oncology, Brasov
Florida Cancer Specialists - Fort Myers (New Hampshire Ct), Fort Myers
Masarykuv onkologicky ustav, Brno
Urocentrum Praha s.r.o., Prague
Vseobecna fakultni nemocnice v Praze, Prague
Fakultni Thomayerova Nemocnice; Revmatologicke Oddeleni, Prague
Alexandras Hospital; Dept. of Clin. Therapeutics, Athens Uni School of Medicine, Athens
Univ General Hosp Heraklion; Medical Oncology, Heraklion
University Hospital of Larissa; Oncology, Larissa
University Hospital of Patras Medical Oncology, Pátrai
Metropolitan Hospital; 2Nd Oncology Clinic, Piraeus
Het Nederlands Kanker Inst, Amsterdam
Vu Medisch Centrum; Afdeling Longziekten, Amsterdam
UMC St Radboud, Nijmegen
Sint Franciscus Gasthuis; Inwendige Geneeskunde, Rotterdam
MC Haaglanden; Oncologie, The Hague
Prof. Dr. Th. Burghele Clin Urology Hosp, Bucharest
Hospital General Universitario de Elche; Servicio de Oncologia, Elche
Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia, Badalona
Hospital Univ Vall d'Hebron; Servicio de Oncologia, Sant Andreu de la Barca
Queen Elizabeth Hospital; Centre for Clinical Haematology, Birmingham
Gartnavel General Hospital, Glasgow
St. James University Hospital; Pharmacy Department, Leeds
The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool
Sarah Cannon Research Institute, London
The Royal Marsden Hospital, Sutton
Lead Sponsor
Genentech, Inc.
INDUSTRY